Literature DB >> 5047261

Abnormal carbohydrate metabolism in patients with liver cirrhosis; in vitro study.

V Dzúriková, T R Niederland, E Brixová, R Dzúrik, V Hupková, J Holomán.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5047261     DOI: 10.1007/bf01212262

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  14 in total

1.  Glucose tolerance and diabetes in chronic liver disease.

Authors:  C Megyesi; E Samols; V Marks
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

2.  Glucose utilization in muscle during uremia; in vitro study.

Authors:  R Dzúrik; E Valovicová
Journal:  Clin Chim Acta       Date:  1970-10       Impact factor: 3.786

3.  Forearm metabolism in patients with chronic liver disease.

Authors:  G A Klassen; A Aronoff; G Karpati
Journal:  Clin Sci       Date:  1969-10       Impact factor: 6.124

4.  Cirrhosis and diabetes. IV. Effect of potassium chloride administration on glucose and insulin metabolism.

Authors:  H O Conn
Journal:  Am J Med Sci       Date:  1970-06       Impact factor: 2.378

5.  [Disturbances of carbohydrate regulation in hepatic lesions].

Authors:  P Magnenat
Journal:  Helv Med Acta       Date:  1970-12

6.  [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].

Authors:  K Kopetz; P Wehrmann
Journal:  Klin Wochenschr       Date:  1970-11-01

7.  [Diminished glucose tolerance and increases insulin response in cirrhosis].

Authors:  J P Felber; P Magnenat; A Vannotti
Journal:  Schweiz Med Wochenschr       Date:  1967-11-18

8.  The effect of uremic serum on carbohydrate metabolism in rat diaphragm.

Authors:  R Dzúrik; B Krajci-Lazáry
Journal:  Experientia       Date:  1967-10-15

9.  Quantitative Determination of Carbohydrates With Dreywood's Anthrone Reagent.

Authors:  D L Morris
Journal:  Science       Date:  1948-03-05       Impact factor: 47.728

10.  [Intravenous injections of glucose, insulin and tolbutamide in healthy persons, diabetics, cirrhotics, and patients with insuloma (together with a contribution on the diagnostic value of the tolbutamide tests)].

Authors:  W CREUTZFELDT; K WILLE; H KAUP
Journal:  Dtsch Med Wochenschr       Date:  1962-10-26       Impact factor: 0.628

View more
  1 in total

1.  Isolation of an inhibitor responsible for abnormal glucose utilization in liver disease.

Authors:  V Dzúriková; T R Niederland; P Cernácek; R Dzúrik
Journal:  Acta Diabetol Lat       Date:  1974 Jul-Aug
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.